New blood test could tell who benefits from immunotherapy

NCT ID NCT07246759

First seen Jan 11, 2026 · Last updated Jun 01, 2026 · Updated 20 times

Summary

This study aims to create a blood test that predicts whether immunotherapy will work for people with certain cancers, including lung, skin, breast, kidney, and head and neck cancers. Researchers will analyze a type of white blood cell called neutrophils in samples from 600 patients before they start treatment. The goal is to build a computer model that estimates the chance of benefit, helping doctors choose the best therapy for each person.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Heidelberg University Hospital

    Heidelberg, 69120, Germany

    Contact Email: •••••@•••••

    Contact

  • Intituto Europeo di Oncologia SRL

    Milan, 20121, Italy

    Contact

    Contact Email: •••••@•••••

  • Virgen Macarena University Hospital - Servicio Andaluz de Salud

    Seville, 41071, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.